A recent Chancery decision in Tesaro, Inc. v. Anaptyseio, Inc., C.A. No. 2025-1357-KSJM (Del. Ch. April 24, 2026), analyzed claims of repudiation or anticipatory breach of a collaboration agreement between two pharmaceutical companies regarding the development of a cancer drug. The court, in an issue of first impression, analyzed Delaware’s recently amended Anti-SLAPP statute which
repudiation
Primer on Contract Damages and Options for Non-Breaching Party
By Francis Pileggi on
Posted in Court of Chancery Updates
Henkel Corp. v. Innovative Brands Holdings, LLC, C.A. No. 3663-VCN (Del. Ch. Jan. 31, 2013).
Issue Addressed
The only issue addressed in this decision on cross-motions for summary judgment was the amount of damages based on a stipulation as to liability for breach. In the course of its analysis, however, the court examines the…